IMIC(SZ:000516) Zhong Guo Jing Ji Wang·2025-12-04 03:05Core Viewpoint - International Medical (000516.SZ) has announced a plan to issue shares to specific investors in 2025, aiming to raise up to 1,007.54 million yuan for various projects and working capital [1][2]. Group 1: Share Issuance Details - The share issuance will target no more than 35 specific investors, including qualified institutional investors and individuals [1]. - The pricing for the shares will be set at no less than 80% of the average trading price over the 20 trading days prior to the issuance [1][2]. - The total number of shares to be issued will not exceed 30% of the company's total share capital before the issuance, amounting to a maximum of 671,669,025 shares [2]. Group 2: Fund Allocation - The funds raised will be allocated as follows: - Smart Health Project: 637.61 million yuan (63.28%) - Proton Therapy Center Phase II: 99.93 million yuan (9.92%) - Working Capital: 270 million yuan (26.80%) - The total investment for these projects is estimated at 1,121.26 million yuan [3]. Group 3: Company Financial Performance - As of the announcement date, the company's total share capital is 2,238,896,753 shares, with the actual controller holding 32.10% of voting rights [4]. - The company reported a revenue of 961.13 million yuan for the latest quarter, a decrease of 18.95% year-on-year, and a net loss attributable to shareholders of 128.69 million yuan [8][9]. - For the year-to-date, the company achieved a revenue of 2,995.44 million yuan, down 16.94% year-on-year, with a net loss of 293.66 million yuan [9][10]. Group 4: Historical Financial Trends - The company has experienced a continuous decline in net profit over the past seven years, with the latest figures showing a net loss of 2.54 billion yuan for 2024, compared to a loss of 3.68 billion yuan in 2023 [10]. - The operating cash flow for the year-to-date is reported at 921.00 million yuan, reflecting a year-on-year increase of 47.67% [9][10].